Knight Therapeutics (04K.MU) Q2 2026 Earnings

7MayConfirmed
Q1 2026
Next
-0
0.02
0.04
0.06

Details

Expected EPS
0.016351320868956
Actual EPS
N/A
Surprise EPS
-0.02
Surprise Percent
+100%

Description

Knight Therapeutics (04K.MU) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts